• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗gp120人IgG1κ单克隆抗体F105在HIV-1感染细胞中的结合动力学、摄取及细胞内蓄积

Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.

作者信息

Clayton Reginald, Ohagen Asa, Goethals Olivia, Smets Alexandra, Van Loock Marnix, Michiels Lieve, Kennedy-Johnston Erin, Cunningham Mark, Jiang Haiyan, Bola Sharon, Gutshall Lester, Gunn George, Del Vecchio Alfred, Sarisky Robert, Hallenberger Sabine, Hertogs Kurt

机构信息

Tibotec BVBA, Generaal De Wittelaan L 11B 3, 2800 Mechelen, Belgium.

出版信息

J Virol Methods. 2007 Jan;139(1):17-23. doi: 10.1016/j.jviromet.2006.08.017. Epub 2006 Oct 10.

DOI:10.1016/j.jviromet.2006.08.017
PMID:17034868
Abstract

The use of targeting moieties is a new and exciting field of scientific research for facilitating the specific delivery of therapeutic agents in HIV-infected patients. The interaction of a potential targeting moiety with its ligand is a crucial factor in the evaluation of a targeted approach for chemotherapeutic intervention. Therefore, we have further characterized the interaction between a potential targeting agent, the monoclonal human antibody F105, and its ligand gp120, a glycoprotein expressed on the surface of HIV-1 infected cells. We demonstrate the specificity of binding and entry of F105 to infected cells. F105 was rapidly taken up into the cell and accumulated in the Golgi apparatus. Kinetic analysis of the F105-gp120 interaction revealed an equilibrium dissociation constant (K(D)) of 0.62 nM, compared with the gp120-CD4 interaction where the K(D) was determined at 35 nM. Consequently, F105 displayed a higher gp120 affinity. This was due to a slower dissociation as compared with the natural ligand. These data further underline the potential of monoclonal antibodies as targeting agents, and offer new insights into the possibility of F105 as a targeting moiety for the delivery of antiretroviral drugs to HIV-1 infected cells.

摘要

使用靶向部分是科学研究中一个全新且令人兴奋的领域,有助于在HIV感染患者中实现治疗药物的特异性递送。潜在靶向部分与其配体之间的相互作用是评估化疗干预靶向方法的关键因素。因此,我们进一步表征了一种潜在靶向剂——人源单克隆抗体F105与其配体gp120(一种在HIV-1感染细胞表面表达的糖蛋白)之间的相互作用。我们证明了F105与感染细胞结合和进入的特异性。F105迅速被细胞摄取并积聚在高尔基体中。F105与gp120相互作用的动力学分析显示平衡解离常数(K(D))为0.62 nM,而gp120与CD4相互作用的K(D)为35 nM。因此,F105表现出更高的gp120亲和力。这是由于与天然配体相比解离较慢。这些数据进一步强调了单克隆抗体作为靶向剂的潜力,并为F105作为将抗逆转录病毒药物递送至HIV-1感染细胞的靶向部分的可能性提供了新的见解。

相似文献

1
Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.抗gp120人IgG1κ单克隆抗体F105在HIV-1感染细胞中的结合动力学、摄取及细胞内蓄积
J Virol Methods. 2007 Jan;139(1):17-23. doi: 10.1016/j.jviromet.2006.08.017. Epub 2006 Oct 10.
2
Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.抗体价态对与细胞表面表达的HIV-1相互作用及病毒中和的影响。
J Immunol. 1994 Mar 1;152(5):2538-45.
3
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.一种与HIV-1/GP120反应、抑制病毒与细胞结合并中和感染的IgG人单克隆抗体。
J Immunol. 1991 Jun 15;146(12):4325-32.
4
Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody.重链恒定区对人单克隆抗体抗原结合及HIV-1中和作用的影响
J Immunol. 1995 Oct 1;155(7):3638-44.
5
Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120.针对1型人类免疫缺陷病毒糖蛋白120的CD4结合位点的人源单克隆抗体的I期研究。
AIDS Res Hum Retroviruses. 1998 May 1;14(7):545-50. doi: 10.1089/aid.1998.14.545.
6
Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.一种HIV-1中和性IgG人单克隆抗体的功能活性:抗体依赖的细胞介导的细胞毒性作用及补体介导的裂解作用
AIDS Res Hum Retroviruses. 1992 May;8(5):553-8. doi: 10.1089/aid.1992.8.553.
7
Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.封装于靶向gp120脂质体中的蛋白酶抑制剂对HIV-1复制具有持续且特异性的体外抑制作用。
Antiviral Res. 2009 Nov;84(2):142-9. doi: 10.1016/j.antiviral.2009.08.003. Epub 2009 Aug 20.
8
Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1.人源单克隆抗体F105在感染1型人类免疫缺陷病毒人群中的药代动力学
Clin Pharmacol Ther. 1996 Jun;59(6):662-7. doi: 10.1016/S0009-9236(96)90006-5.
9
Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression.对一种由人单克隆抗体识别的HIV-1/gp120构象表位的血清抗体丧失与疾病进展相关。
J Acquir Immune Defic Syndr (1988). 1993 Oct;6(10):1093-102.
10
Evaluation of the binding between potential anti-HIV DNA-based drugs and viral envelope glycoprotein gp120 by capillary electrophoresis with laser-induced fluorescence detection.基于激光诱导荧光检测的毛细管电泳法评估潜在的抗HIV DNA类药物与病毒包膜糖蛋白gp120之间的结合
Anal Biochem. 2000 Sep 10;284(2):334-41. doi: 10.1006/abio.2000.4651.

引用本文的文献

1
Targeting strategies for delivery of anti-HIV drugs.抗HIV药物递送的靶向策略。
J Control Release. 2014 Oct 28;192:271-83. doi: 10.1016/j.jconrel.2014.08.003. Epub 2014 Aug 10.
2
Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.具有跨亚型人免疫缺陷病毒1型(HIV-1)中和特性且对HIV-1 gp120具有高亲和力的骆驼抗体片段。
J Virol. 2008 Dec;82(24):12069-81. doi: 10.1128/JVI.01379-08. Epub 2008 Oct 8.